help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 13, No. 6 732-
doi:10.1210/jcem-13-6-732
Copyright © 1953 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LISSER, H.
Right arrow Articles by GORDAN, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LISSER, H.
Right arrow Articles by GORDAN, G. S.

DOSAGE OF METHYLTESTOSTERONE

H. LISSER, M.D.*, ROBERTO F. ESCAMILLA, M.D.{dagger} and GILBERT S. GORDAN, M.D.{ddagger}

Endocrine Clinic, Department of Medicine, University of California School of Medicine San Francisco 22, California

In the Journal of Clinical Endocrinology and Metabolism 13: 235 (Feb.). 1953, Doctor Carl Heller is quoted as stating that the dose of methyltestosterone given sublingually or buccally for the management of male eunuchoidism is 40 to 80 mg. per day. This is contrary to our experience, which has been that doses over 40 mg. per day can rarely be given such patients by the sublingual or buccal route without the production of symptoms of overdosage, viz., priapism, edema, or gynecomastia. In over 40 hypogonadal patients followed in this clinic we have found it possible to initiate improvement with doses of 20 to 40 mg. per day and to maintain all the patients by the administration of 10 to 20 mg. of methyltestosterone daily, given by the sublingual or buccal route. The first 12 such patients were reported by Escamilla and Gordan (Efficacy of Testosterone Compounds Administered Sublingually to Hypogonadal Men, J. Clin. Endocrinol. 10: 248–264 (Feb.) 1950). Indeed, an occasional patient has been observed who demonstrates full androgenic effects on as little as 5 mg. of methyltestosterone, sublingually or buccally, per day.

* Clinical Professor of Medicine & Endocrinology

{dagger} Associate Clinical Professor of Medicine

{ddagger} Assistant Professor of Medicine







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1953 by The Endocrine Society